Medical 21, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Oct 23, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Aug 21, 2025 · D/A | Oct 23, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $20,000,000 | $20,000,000 | $0 |
| Reported amount sold | $10,017,500 | $550,000 | $-9,467,500 |
| Reported investor count | — | 3 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001437749-25-027519 · Later SEC source: 0001437749-26-033301
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $20,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $550,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Reg A+ (Form 1-A / 1-K / 1-U) filings by this issuer
Form D filings (2)
-
0001437749-26-033301D · Oct 23, 2026 · BiotechnologyOffering: $20,000,000Sold: $550,000
Compared with 0001437749-25-027519:
- Reported amount sold: $10,017,500 → $550,000
- Reported investor count: Unavailable → 3
-
0001437749-25-027519D/A · Aug 21, 2025 · BiotechnologyOffering: $20,000,000Sold: $10,017,500